HemaSphere (Jul 2024)
Refinement of the prognostic impact of somatic CEBPA bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG)
- Frank G. Rücker,
- Andrea Corbacioglu,
- Julia Krzykalla,
- Sibylle Cocciardi,
- Claudia Lengerke,
- Ulrich Germing,
- Gerald Wulf,
- Maisun A. Samra,
- Lino L. Teichmann,
- Michael Lübbert,
- Michael W. M. Kühn,
- Martin Bentz,
- Jörg Westermann,
- Lars Bullinger,
- Verena I. Gaidzik,
- Annika Meid,
- Sophia Aicher,
- Frank Stegelmann,
- Daniela Weber,
- Anika Schrade,
- Felicitas Thol,
- Michael Heuser,
- Arnold Ganser,
- Axel Benner,
- Hartmut Döhner,
- Konstanze Döhner,
- for the German‐Austrian Acute Myeloid Leukemia Study Group (AMLSG)
Affiliations
- Frank G. Rücker
- Department of Internal Medicine III University Hospital of Ulm Ulm Germany
- Andrea Corbacioglu
- Department of Internal Medicine III University Hospital of Ulm Ulm Germany
- Julia Krzykalla
- Division of Biostatistics German Cancer Research Center Heidelberg Germany
- Sibylle Cocciardi
- Department of Internal Medicine III University Hospital of Ulm Ulm Germany
- Claudia Lengerke
- Medical Clinic, Department of Hematology, Oncology, Clinical Immunology and Rheumatology University Hospital Tübingen Tübingen Germany
- Ulrich Germing
- Department of Hematology, Oncology and Clinical Immunology Heinrich Heine University Düsseldorf Germany
- Gerald Wulf
- Department of Hematology and Medical Oncology University Medical Center Göttingen Göttingen Germany
- Maisun A. Samra
- Department of Internal Medicine IV University Hospital of Gießen Gießen Germany
- Lino L. Teichmann
- Department of Medicine and Polyclinic III Bonn University Hospital Bonn Germany
- Michael Lübbert
- Department of Hematology, Oncology and Stem Cell Transplantation University of Freiburg Medical Center Freiburg Germany
- Michael W. M. Kühn
- Department of Hematology and Oncology University Medical Center Mainz Mainz Germany
- Martin Bentz
- Department of Internal Medicine III Hospital of Karlsruhe Karlsruhe Germany
- Jörg Westermann
- Department of Hematology, Oncology and Tumor Immunology Charité University Medicine Berlin Germany
- Lars Bullinger
- Department of Hematology, Oncology and Tumor Immunology Charité University Medicine Berlin Germany
- Verena I. Gaidzik
- Department of Internal Medicine III University Hospital of Ulm Ulm Germany
- Annika Meid
- Department of Internal Medicine III University Hospital of Ulm Ulm Germany
- Sophia Aicher
- Department of Internal Medicine III University Hospital of Ulm Ulm Germany
- Frank Stegelmann
- Department of Internal Medicine III University Hospital of Ulm Ulm Germany
- Daniela Weber
- Department of Internal Medicine III University Hospital of Ulm Ulm Germany
- Anika Schrade
- Department of Internal Medicine III University Hospital of Ulm Ulm Germany
- Felicitas Thol
- Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation Hannover Medical School Hannover Germany
- Michael Heuser
- Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation Hannover Medical School Hannover Germany
- Arnold Ganser
- Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation Hannover Medical School Hannover Germany
- Axel Benner
- Division of Biostatistics German Cancer Research Center Heidelberg Germany
- Hartmut Döhner
- Department of Internal Medicine III University Hospital of Ulm Ulm Germany
- Konstanze Döhner
- Department of Internal Medicine III University Hospital of Ulm Ulm Germany
- for the German‐Austrian Acute Myeloid Leukemia Study Group (AMLSG)
- DOI
- https://doi.org/10.1002/hem3.123
- Journal volume & issue
-
Vol. 8,
no. 7
pp. n/a – n/a
Abstract
No abstracts available.
